Lobe Sciences Announces Appointment of New Board of Directors and New Management Team Page 1

Lobe Sciences Ltd (“Lobe Sciences” or the “Company”) (CSE: LOBE), (OTCQB: LOBEF)Lobe Sciences, Inc., a biopharmaceutical company focused on developing products to treat diseases with unmet medical needs, today announced that a new board of directors (“Board”) was elected at the Company’s annual general meeting, with shareholders electing the three previously announced nominees: Dr. Frederick D. Sancilio, Dr. Harry Jacobson and Mr. Wesley Ramjeet. Lobe Sciences also announced that Mr. Philip Young and Mr. Baxter Phillips have elected to leave the Company to pursue other opportunities. The Board has appointed Dr. Sancilio as Chairman of the Board and Chief Executive Officer of the Company.

Dr. Sancilio, Chairman and CEO, said, “While I regret the departure of Mr. Young and Mr. Phillips, I am excited about the opportunity to implement plans focused on creating shareholder value while meeting the needs of patients with serious unmet medical needs.”